Karen Reeves, MD
About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us
Karen Reeves, MD
President and Chief Medical Officer

Karen Reeves, M.D. is the President and Chief Medical Officer at AZTherapies, a Boston based private biopharmaceutical company, developing treatments for serious neurological illnesses, including Alzheimer’s Disease, by targeting neuroinflammation.  AZTherapies has raised over $130 million.

Dr. Reeves began her career at Pfizer and served in roles of increasing responsibility throughout her twice tenure at Pfizer.  She has more than 25 years in the pharmaceutical and biotech industry in clinical R&D, business development, operational development, regulatory, and management.   She has provided leadership across multiple therapeutic areas including neuroscience, oncology, immunology, infectious diseases, cardiovascular and metabolic disorders, and rare diseases.  Roles included VP Worldwide Clinical Development, VP Neurosciences Development, Head Infectious Disease Regulatory, and, prior to joining AZTherapies, VP Head Global Clinical Submissions Quality, developing innovative solutions to drug development and providing mentorship to asset team leaders.  While at Pfizer, Dr. Reeves was the team leader for Chantix that won the Prix Galien for Best Pharmaceutical.  Chantix was filed a year ahead of schedule and sold $800 million in its first year.

In addition, Dr. Reeves served as Global Head of Medical Science at Astellas, Japanese big Pharma, represented Astellas at the European Pharmaceutical Trade Organization, EFPIA, Scientific Regulatory, and Manufacturing Committee in Brussels, led the OSI Oncology (Tarceva) Clinical Integration Team, and was the responsible executive for the successful filing of Myrbetriq.

Dr. Reeves has championed machine learning and AI, won Pfizer’s Individual Achievement Award for bridging development and commercial, and the “Scrappy” Entrepreneurial Award for strategic innovation in Asia.

Dr. Reeves received her BA from Yale University and MD from the University of Vermont.  She has served on the faculty of Tufts and Harvard Medical Schools.  Dr. Reeves is driven by collaboration, building great teams, and expediting drug development through strategic focus, innovation, and regulatory policy to improve the lives of patients everywhere.

© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us